260 related articles for article (PubMed ID: 33333132)
1. Magnetic resonance spectroscopy studies of substance use disorders: Current landscape and potential future directions.
Kohut SJ; Kaufman MJ
Pharmacol Biochem Behav; 2021 Jan; 200():173090. PubMed ID: 33333132
[TBL] [Abstract][Full Text] [Related]
2. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
[TBL] [Abstract][Full Text] [Related]
3. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
4. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
Reid MA; White DM; Kraguljac NV; Lahti AC
Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
[TBL] [Abstract][Full Text] [Related]
5. Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.
Ercan E; Magro-Checa C; Valabregue R; Branzoli F; Wood ET; Steup-Beekman GM; Webb AG; Huizinga TW; van Buchem MA; Ronen I
Brain; 2016 May; 139(Pt 5):1447-57. PubMed ID: 26969685
[TBL] [Abstract][Full Text] [Related]
6. Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.
Licata SC; Renshaw PF
Ann N Y Acad Sci; 2010 Feb; 1187():148-71. PubMed ID: 20201852
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy.
Duncan JS
Epilepsia; 1996 Jul; 37(7):598-605. PubMed ID: 8681890
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy in patients with ischemic stroke.
Federico F; Conte C; Simone IL; Giannini P; Liguori M; Picciola E; Tortorella C; Ferrari E
Ital J Neurol Sci; 1994 Nov; 15(8):413-20. PubMed ID: 7875959
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
McKnight TR
Semin Oncol; 2004 Oct; 31(5):605-17. PubMed ID: 15497114
[TBL] [Abstract][Full Text] [Related]
10. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cerebral structural changes in systemic lupus erythematosus by proton MR spectroscopy.
Sibbitt WL; Haseler LJ; Griffey RH; Hart BL; Sibbitt RR; Matwiyoff NA
AJNR Am J Neuroradiol; 1994 May; 15(5):923-8. PubMed ID: 8059662
[TBL] [Abstract][Full Text] [Related]
12. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
Yildiz-Yesiloglu A; Ankerst DP
Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
[TBL] [Abstract][Full Text] [Related]
13. Correlations between DTI-derived metrics and MRS metabolites in tumour regions of glioblastoma: a pilot study.
Flores-Alvarez E; Anselmo Rios Piedra E; Cruz-Priego GA; Durand-Muñoz C; Moreno-Jimenez S; Roldan-Valadez E
Radiol Oncol; 2020 Sep; 54(4):394-408. PubMed ID: 32990651
[TBL] [Abstract][Full Text] [Related]
14. Integrated imaging of [
Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term stress-like cortisol on cerebral metabolism: a proton magnetic resonance spectroscopy study at 3.0 T.
Scheel M; Ströhle A; Bruhn H
J Psychiatr Res; 2010 Jun; 44(8):521-6. PubMed ID: 20022344
[TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation with Lactobacillus rhamnosus JB-1 restores brain neurochemical balance and mitigates the progression of mood disorder in a rat model of chronic unpredictable mild stress.
Kochalska K; Oakden W; Słowik T; Chudzik A; Pankowska A; Łazorczyk A; Kozioł P; Andres-Mach M; Pietura R; Rola R; Stanisz GJ; Orzylowska A
Nutr Res; 2020 Oct; 82():44-57. PubMed ID: 32961399
[TBL] [Abstract][Full Text] [Related]
17. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
18. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance spectroscopy of human brain cortex: Relationships between concentrations of some crucial metabolites.
Semenova NA; Varfolomeev SD; Akhadov TA; Lukovenkov AV
Dokl Biochem Biophys; 2011; 436():49-52. PubMed ID: 21369904
[No Abstract] [Full Text] [Related]
20. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
